$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol 원문보기

BMJ open, v.6 no.11, 2016년, pp.e011898 -   

Morgan, Ann D (Respiratory Epidemiology, Occupational Medicine and Public Health , National Heart and Lung Institute, Imperial College London , London , UK) ,  Sharma, Chetna (University College London , London , UK) ,  Rothnie, Kieran J (Respiratory Epidemiology, Occupational Medicine and Public Health , National Heart and Lung Institute, Imperial College London , London , UK) ,  Quint, Jennifer K (Respiratory Epidemiology, Occupational Medicine and Public Health , National Heart and Lung Institute, Imperial College London , London , UK)

Abstract AI-Helper 아이콘AI-Helper

IntroductionThere is good evidence to suggest that chronic obstructive pulmonary disease (COPD) increases the risk of ischaemic heart disease, in particular myocardial infarction (MI). The relationship between stroke and COPD, however, is not as well established, and studies conducted to date have g...

주제어

참고문헌 (18)

  1. 1 GOLD . Global strategy for the diagnosis, mangagement and prevention of chronic pulmonary disease (updated 2015) . Global Initiative for Chronic Obstructive Lung Disease , 2015 . 

  2. 2 Vanfleteren LE , Spruit MA , Groenen M Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 2013 ; 187 : 728 – 35 . 10.1164/rccm.201209-1665OC 23392440 

  3. 3 Divo M , Cote C , de Torres JP Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 2012 ; 186 : 155 – 61 . 10.1164/rccm.201201-0034OC 22561964 

  4. 4 Müllerova H , Agusti A , Erqou S Cardiovascular comorbidity in COPD: systematic literature review . Chest 2013 ; 144 : 1163 – 78 . 10.1378/chest.12-2847 23722528 

  5. 5 Bhatt SP , Dransfield MT Chronic obstructive pulmonary disease and cardiovascular disease . Transl Res 2013 ; 162 : 237 – 51 . 10.1016/j.trsl.2013.05.001 23727296 

  6. 6 Chen W , Thomas J , Sadatsafavi M Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis . Lancet Respir Med 2015 ; 3 : 631 – 9 . 10.1016/S2213-2600(15)00241-6 26208998 

  7. 7 Rothnie KJ , Yan R , Smeeth L Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive disease (COPD): a systematic review and meta-analysis . BMJ Open 2015 ; 5 : e007824 10.1136/bmjopen-2015-007824 

  8. 8 WHO . Health statistics and information systems: projection of mortality and causes of death, 2015 and 2030 . Geneva : World Health Organization , 2015 ( accessed 24 Nov 2015 ). 

  9. 9 Feary JR , Rodrigues LC , Smith CJ Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care . Thorax 2010 ; 65 : 956 – 62 . 10.1136/thx.2009.128082 20871122 

  10. 10 Finkelstein J , Cha E , Scharf S Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular comorbidity . Int J COPD 2009 ; 4 : 337 – 49 . 10.2147/COPD.S6400 

  11. 11 Schneider C , Bothner U , Jick SS Chronic obstructive pulmonary disease and the risk of cardiovascular diseases . Eur J Epidemiol 2010 ; 25 : 253 – 60 . 10.1007/s10654-010-9435-7 20191376 

  12. 12 Doehner W , Haeusler KG , Endres M Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease . Respir Med 2011 ; 105 (Suppl 1 ): S12 – 19 . 10.1016/S0954-6111(11)70005-1 22015080 

  13. 13 Lahousse L , Tiemeier H , Ikram MA Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review . Respir Med 2015 ; 109 : 1371 – 80 . 10.1016/j.rmed.2015.07.014 26342840 

  14. 14 Arboix A , Morcillo C , Garcia-Eroles L Different vascular risk factor profiles in ischemic stroke subtypes: a study from the “Sagrat Cor Hospital of Barcelona Stroke Registry” . Acta Neurol Scand 2000 ; 102 : 264 – 70 . 10.1034/j.1600-0404.2000.102004264.x 11071113 

  15. 15 Shamseer L , Moher D , Clarke M Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation . BMJ 2015 ; 349 : g7647 10.1136/bmj.g7647 

  16. 16 Sanderson S , Tatt ID , Higgins JP Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography . Int J Epidemiol 2007 ; 36 : 666 – 76 . 10.1093/ije/dym018 17470488 

  17. 17 Wells GA , Shea B , O'Connell D The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses . Ottawa : The Ottawa Hospital Research Institute ( http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 4 Mar 2016 )). 

  18. 18 GRADE Working Group . GRADE working group [website]. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group ( http://www.gradeworkinggroup.org/publications/JCE_series.htm (accessed 4 Mar 2016) ). 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로